Nanjing Vazyme Biotech Co., Ltd

XSSC:688105 Voorraadrapport

Marktkapitalisatie: CN¥9.0b

Nanjing Vazyme Biotech Toekomstige groei

Future criteriumcontroles 5/6

Nanjing Vazyme Biotech is forecast to grow earnings and revenue by 76.3% and 23.8% per annum respectively. EPS is expected to grow by 75.8% per annum. Return on equity is forecast to be 7.7% in 3 years.

Belangrijke informatie

76.3%

Groei van de winst

75.8%

Groei van de winst per aandeel

Biotechs winstgroei44.8%
Inkomstengroei23.8%
Toekomstig rendement op eigen vermogen7.7%
Dekking van analisten

Low

Laatst bijgewerkt19 Sep 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

XSSC:688105 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262,416365N/A4751
12/31/20251,970297N/A3971
12/31/20241,572104N/A4361
9/30/20241,40324772N/A
6/30/20241,36426-6734N/A
3/31/20241,285-1512181N/A
12/31/20231,286-71-80153N/A
9/30/20232,133-232152589N/A
6/30/20232,520-101126649N/A
3/31/20232,896112-128553N/A
12/31/20223,569594-228735N/A
9/30/20222,885878-367445N/A
6/30/20222,663900-291440N/A
3/31/20222,302773-123453N/A
12/31/20211,869678355617N/A
9/30/20211,715767315583N/A
12/31/20201,564822651804N/A
12/31/201926826-515N/A
12/31/20181711-36-4N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 688105's forecast earnings growth (76.3% per year) is above the savings rate (2.9%).

Winst versus markt: 688105's earnings (76.3% per year) are forecast to grow faster than the CN market (25.8% per year).

Hoge groeiwinsten: 688105's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 688105's revenue (23.8% per year) is forecast to grow faster than the CN market (14% per year).

Hoge groei-inkomsten: 688105's revenue (23.8% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 688105's Return on Equity is forecast to be low in 3 years time (7.7%).


Ontdek groeibedrijven